Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,000 | 3 | 74.9% |
| Consulting Fee | $6,000 | 1 | 25.0% |
| Food and Beverage | $45.65 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Verity Pharmaceuticals Inc. | $24,021 | 5 | $0 (2024) |
| ABBVIE INC. | $25.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,025 | 4 | Verity Pharmaceuticals Inc. ($18,000) |
| 2023 | $6,000 | 1 | Verity Pharmaceuticals Inc. ($6,000) |
| 2021 | $20.65 | 1 | Verity Pharmaceuticals Inc. ($20.65) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/03/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| Category: Prostate cancer | ||||||
| 06/30/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| Category: Prostate cancer | ||||||
| 04/02/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| Category: Prostate cancer | ||||||
| 07/10/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: Prostate cancer | ||||||
| 03/30/2021 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Prostate cancer | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 79 | 84 | $8,063 | $4,176 |
| 2022 | 2 | 88 | 94 | $9,074 | $5,319 |
| 2021 | 3 | 119 | 132 | $13,130 | $8,295 |
| 2020 | 2 | 113 | 128 | $10,481 | $6,583 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 64 | $5,806 | $2,820 | 48.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $2,257 | $1,356 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 76 | $7,019 | $4,192 | 59.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $2,055 | $1,127 | 54.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 79 | 92 | $8,535 | $5,251 | 61.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 22 | 22 | $2,510 | $1,535 | 61.2% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2021 | 18 | 18 | $2,085 | $1,509 | 72.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 92 | 107 | $8,177 | $5,096 | 62.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 21 | 21 | $2,304 | $1,487 | 64.5% |
About Dr. Ricardo Saade, M.D
Dr. Ricardo Saade, M.D is a Urology healthcare provider based in Manati, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235199167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ricardo Saade, M.D has received a total of $24,046 in payments from pharmaceutical and medical device companies, with $18,025 received in 2024. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,000).
As a Medicare-enrolled provider, Saade has provided services to 399 Medicare beneficiaries, totaling 438 services with total Medicare billing of $24,373. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Manati, PR
- Active Since 03/24/2006
- Last Updated 03/07/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235199167
Products in Payments
- Trelstar (Drug) $24,021
- BOTOX (Biological) $25.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.